4//SEC Filing
ARNETT JEAN M 4
Accession 0001626533-18-000002
CIK 0001493712other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 2:29 PM ET
Size
14.8 KB
Accession
0001626533-18-000002
Insider Transaction Report
Form 4
Cell MedX Corp.CMXC
ARNETT JEAN M
DirectorVP, Corporate Strategy10% Owner
Transactions
- Other
Stock Options (Right to Buy)
2016-09-26−1,250,000→ 0 totalExercise: $0.05→ Common Stock (1,250,000 underlying) - Other
Stock Options (Right to Buy)
2016-09-26−1,250,000→ 0 totalExercise: $0.05→ Common Stock (1,250,000 underlying) - Other
Stock Options (Right to Buy)
2016-09-26−1,250,000→ 0 totalExercise: $0.05→ Common Stock (1,250,000 underlying) - Other
Stock Options (Right to Buy)
2016-09-26−2,500,000→ 0 totalExercise: $0.05→ Common Stock (2,500,000 underlying) - Other
Stock Options (Right to Buy)
2016-09-26−2,500,000→ 0 totalExercise: $0.05→ Common Stock (2,500,000 underlying)
Footnotes (6)
- [F1]The Options were to vest upon the completion of first clinical trial and delivery of final white paper for the first clinical trial.
- [F2]The Options were to vest upon the design and commencement of the second clinical trial.
- [F3]The Options were to vest upon the completion of second clinical trial and delivery of final white paper for the second clinical trial.
- [F4]The Options were to vest upon the design and commencement of the third clinical trial.
- [F5]The Options were to vest upon the completion of the third clinical trial and delivery of final white paper for the third clinical trial.
- [F6]Options that would have vested were to expire 5 years after vesting. Options that have not vested would have expired on 12/31/2019.
Documents
Issuer
Cell MedX Corp.
CIK 0001493712
Entity typeother
Related Parties
1- filerCIK 0001626660
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 2:29 PM ET
- Size
- 14.8 KB